全文获取类型
收费全文 | 4887篇 |
免费 | 341篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 64篇 |
妇产科学 | 83篇 |
基础医学 | 649篇 |
口腔科学 | 91篇 |
临床医学 | 491篇 |
内科学 | 1193篇 |
皮肤病学 | 81篇 |
神经病学 | 543篇 |
特种医学 | 246篇 |
外科学 | 729篇 |
综合类 | 12篇 |
一般理论 | 2篇 |
预防医学 | 216篇 |
眼科学 | 62篇 |
药学 | 357篇 |
中国医学 | 10篇 |
肿瘤学 | 375篇 |
出版年
2023年 | 40篇 |
2022年 | 166篇 |
2021年 | 303篇 |
2020年 | 138篇 |
2019年 | 179篇 |
2018年 | 168篇 |
2017年 | 126篇 |
2016年 | 173篇 |
2015年 | 185篇 |
2014年 | 224篇 |
2013年 | 275篇 |
2012年 | 394篇 |
2011年 | 412篇 |
2010年 | 244篇 |
2009年 | 192篇 |
2008年 | 300篇 |
2007年 | 328篇 |
2006年 | 271篇 |
2005年 | 268篇 |
2004年 | 230篇 |
2003年 | 201篇 |
2002年 | 180篇 |
2001年 | 28篇 |
2000年 | 28篇 |
1999年 | 24篇 |
1998年 | 31篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 15篇 |
1994年 | 13篇 |
1993年 | 3篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 8篇 |
1975年 | 2篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有5251条查询结果,搜索用时 156 毫秒
51.
52.
Cristian Palmiere Michele Mussap Daniel Bardy Francesco Cibecchini Patrice Mangin 《International journal of legal medicine》2013,127(4):799-808
The first aim of this study was to assess the diagnostic performance of presepsin (sCD14-ST) in postmortem serum from femoral blood compared to procalcitonin (PCT) to detect sepsis-related fatalities. The second aim was to compare sCD14-ST levels found in postmortem serum to the values in pericardial fluid to investigate the usefulness of the latter as an alternative biological fluid. Two study groups were formed, a sepsis-related fatalities group and a control group. Radiology (unenhanced CT scans and postmortem angiographies), autopsies, histology, neuropathology, and toxicology as well as other postmortem biochemistry investigations were performed in all cases. Microbiological investigations on right cardiac blood were carried out exclusively in septic cases. The results of this study indicated that postmortem serum PCT and sCD14-ST levels, individually considered, allowed septic cases to be identified. Even though increases in both PCT and sCD14-ST concentrations were observed in the control cases, coherent PCT and sCD14-ST results in cases with suspected sepsis allowed the diagnosis to be confirmed. Conversely, no relevant correlation was identified between postmortem serum and pericardial fluid sCD14-ST levels in either the septic or control groups. 相似文献
53.
54.
Paola Carpinetti Elisa Donnard Fabiana Bettoni Paula Asprino Fernanda Koyama Andrei Rozanski Jorge Sabbaga Angelita Habr-Gama Raphael B. Parmigiani Pedro A.F. Galante Rodrigo O. Perez Anamaria A. Camargo 《Oncotarget》2015,6(35):38360-38371
Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the mainstay treatment for locally advanced rectal cancer. Variable degrees of tumor regression are observed after nCRT and alternative treatment strategies, including close surveillance without immediate surgery, have been investigated to spare patients with complete tumor regression from potentially adverse outcomes of radical surgery. However, clinical and radiological assessment of response does not allow accurate identification of patients with complete response. In addition, surveillance for recurrence is similarly important for these patients, as early detection of recurrence allows salvage resections and adjuvant interventions. We report the use of liquid biopsies and personalized biomarkers for monitoring treatment response to nCRT and detecting residual disease and recurrence in patients with rectal cancer. We sequenced the whole-genome of four rectal tumors to identify patient-specific chromosomal rearrangements that were used to monitor circulating tumor DNA (ctDNA) in liquid biopsies collected at diagnosis and during nCRT and follow-up. We compared ctDNA levels to clinical, radiological and pathological response to nCRT. Our results indicate that personalized biomarkers and liquid biopsies may not be sensitive for the detection of microscopic residual disease. However, it can be efficiently used to monitor treatment response to nCRT and detect disease recurrence, preceding increases in CEA levels and radiological diagnosis. Similar good results were observed when assessing tumor response to systemic therapy and disease progression. Our study supports the use of personalized biomarkers and liquid biopsies to tailor the management of rectal cancer patients, however, replication in a larger cohort is necessary to introduce this strategy into clinical practice. 相似文献
55.
Clinical Rheumatology - 相似文献
56.
José I Quetglas Juan Dubrot Jaione Bezunartea Miguel F Sanmamed Sandra Hervas-Stubbs Cristian Smerdou Ignacio Melero 《Molecular therapy》2012,20(9):1664-1675
Intratumoral injection of Semliki Forest virus encoding interleukin-12 (SFV-IL-12) combines acute expression of IL-12 and stressful apoptosis of infected malignant cells. Agonist antibodies directed to costimulatory receptor CD137 (4-1BB) strongly amplify pre-existing cellular immune responses toward weak tumor antigens. In this study, we provide evidence for powerful synergistic effects of a combined strategy consisting of intratumoral injection of SFV-IL-12 and systemic delivery of agonist anti-CD137 monoclonal antibodies (mAbs), which was substantiated against poorly immunogenic B16 melanomas (B16-OVA and B16.F10) and TC-1 lung carcinomas. Effector CD8β+ T cells were sufficient to mediate complete tumor eradications. Accordingly, there was an intensely synergistic in vivo enhancement of cytotoxic T lymphocytes (CTL)-mediated immunity against the tumor antigens OVA and tyrosine-related protein-2 (TRP-2). This train of phenomena led to long-lasting tumor-specific immunity against rechallenge, attained transient control of the progression of concomitant tumor lesions that were not directly treated with SFV-IL-12 and caused autoimmune vitiligo. Importantly, we found that SFV-IL-12 intratumoral injection induces bright expression of CD137 on most tumor-infiltrating CD8+ T lymphocytes, thereby providing more abundant targets for the action of the agonist antibody. This efficacious combinatorial immunotherapy strategy offers feasibility for clinical translation since anti-CD137 mAbs are already undergoing clinical trials and development of clinical-grade SFV-IL-12 vectors is in progress. 相似文献
57.
58.
ABSTRACT This paper presents a control strategy that compensates for the nonlinearity in the inexpensive sensors and hardware of a cost effective prosthetic hand. The control strategy uses neural network-based force control and sensory feedback to detect disturbance induced by slippage. The neural network approach is chosen over other nonlinear models because it is easy to implement and it offered the additional advantage of having its parameters easily adjusted over the life span of the device. The proposed strategy was evaluated on a functional multi-digit underactuated prosthetic hand. The initial and incremental forces exerted from each finger were adjusted to balance the amount of disturbance and the deformation of the objects. Experiments were conducted to test the performance of the protocol in situations encountered in activities of daily living. The displacement of each object under three grasping configurations was measured as a performance criterion while the object's mass was changed. The results showed that with the adjusted parameters for each grasping configuration, the control strategy was able to detect the dynamic changes in mass of the object and was also able to successfully adjust the grasping force before the object drops from the hand. 相似文献
59.
60.